1. Homepage
  2. ETF
  3. United Kingdom
  4. London Stock Exchange
  5. Invesco NASDAQ Biotech UCITS ETF Acc - USD
  6. Summary
    SBIO   IE00BQ70R696

INVESCO NASDAQ BIOTECH UCITS ETF ACC - USD

(SBIO)
Delayed London Stock Exchange  -  03:07 2022-07-06 am EDT
40.29 USD   +2.66%
 SummaryQuotesChartsComponents 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
06/30/2022 07/01/2022 07/04/2022 07/05/2022 07/06/2022 Date
38.425(c) 38.98(c) 39.195(c) 39.245(c) 40.29 Last
-0.63% +1.44% +0.55% +0.13% +2.66% Change
906 10 260 2 864 8 723 551 Volume
More quotes
Investment objective
The Invesco NASDAQ Biotech UCITS ETF Acc aims to provide the performance of the NASDAQ Biotechnology Index, after fees. The index comprises biotechnology and pharmaceuticals companies (as defined by ICB) listed on the NASDAQ Stock Market. Stocks are filtered to meet minimum market capitalisation and liquidity requirements. They are then weighted by modified market capitalisation: the largest five constituents are capped at 8%; the remaining constituents are capped at 4%. The index is rebalanced quarterly and reviewed annually in December.
All the latest ETF news
07/05Emerging Asian equities post biggest foreign outflows since March 2020
07/04TRACKINSIGHT : U.S. stocks tumble amid fears of inflation and potential recession     
TI
07/04ETF OVERVIEW : Information technology, Consumer staples, Emerging markets
07/04China stocks rise on healthcare boost, ETF Connect launch; HK dips
RE
07/04Vanguard MSCI Australian Large Companies Index ETF Announces Quarterly Distribution
CI
07/04Vanguard FTSE Emerging Markets Shares ETF Announces Distribution for the Quarter Ending..
CI
07/04Vanguard Australian Shares Index ETF Announces Distribution for the Quarter Ended 30 Ju..
CI
07/04Shanghai stocks rise on ETF Connect boost, COVID woes cap gains
RE
More ETF news
Competing ETFs for Index NASDAQ Biotechnology Total Return Ind... ETF Data by Trackinsight
ETFVar. 5days1st jan.RatingProviderCategory and Sector
INVESCO NASDAQ BIOTECH ACC 0.85%-19.44%InvescoEquities - Biotechnology
ISHARES NASDAQ US BIOTECHNOL...0.85%-19.43%iSharesEquities - Biotechnology
PROSHARES ULTRA NASDAQ BIOTE...-0.98%-37.75%-ProSharesEquities - Biotechnology
ISHARES NASDAQ US BIOTECHNOL...0.74%-19.82%iSharesEquities - Biotechnology
PROSHARES ULTRASHORT NASDAQ ...-8.50%22.88%-ProSharesEquities - Biotechnology
Plus d'ETFs
News in other languages on INVESCO NASDAQ BIOTECH UCITS ETF ACC - USD

- No features available -

More news
ETF Ratings by Trackinsight  TrackInsightTM ETF Ratings – Methodology
  More 
Chart INVESCO NASDAQ BIOTECH UCITS ETF ACC - USD
Duration : Period :
Invesco NASDAQ Biotech UCITS ETF Acc - USD Technical Analysis Chart | MarketScreener
Full-screen chart
Investment Themes
Asset Classes Equities
Geographical Zones United_States
Sector Biotechnology
Size Large & Mid Cap
Development Developed
Weighting Schemes Market Cap Weighted
Description
Index ETF NASDAQ Biotechnology Total Return Index - USD
Related indices
Currency USD
Management fees 0.4%
AuM (2022-05-10) 544.83 M USD
Provider Invesco
Features and characteristics
Jurisdiction Ireland
Structure Open-end Investment Company
Date of creation 2014-11-07
Dividend Policy Capitalization
Replication Method Indirect (Synthetic)
Replication Model Unfunded Swap
Heatmap :
AuM evolution (2022-05-10)
Last one 544.83 M USD
1-month 576.58 M USD
3 months 534.38 M USD
6 months 653.25 M USD
1-year 591.31 M USD